Loading clinical trials...
Loading clinical trials...
Prospective, Observational , Multicenter Study of Effectiveness of Efanesoctocog Alfa on Long-term Joint Health in Patients With Hemophilia A
Conditions
Interventions
Efanesoctocog Alfa BIVV001
Locations
28
United States
Banner MD Anderson Cancer Center- Site Number : 8400008
Gilbert, Arizona, United States
Loma Linda University- Site Number : 8400015
Loma Linda, California, United States
Orthopedic Institute for Children- Site Number : 8400004
Los Angeles, California, United States
The Center for Inherited Blood Disorders- Site Number : 8400001
Orange, California, United States
University of Colorado Hemophilia and Thrombosis Center- Site Number : 8400019
Aurora, Colorado, United States
William A. Shands Hospital at the University of Florida- Site Number : 8400032
Gainesville, Florida, United States
Start Date
June 30, 2023
Primary Completion Date
June 6, 2028
Completion Date
September 17, 2030
Last Updated
October 2, 2025
NCT06820515
NCT07226206
NCT05987449
NCT04563520
NCT04645199
NCT05936580
Lead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions